VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Understanding Yutian Medical Shanghai Deal

<< Previous

Bullboard Posts

Next >>

Comment by Lieob007on Mar 04, 2021 9:02am

120 Views

Post# 32713342

RE:RE:RE:RE:RE:RE:Understanding Yutian Medical Shanghai Deal

You are not an idiot, you are smart, evertime you post here, it will be a hard day for VPT. So we all know your aim, good job. For the longs, it is time to buy at lower price, we should thank you anyway.
Two weeks or two months are not too much differene, the trend is going up, good luck for all the longs.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale